|
EP2662081A1
|
|
Therapeutic use of indole-dihydro-imidazole derivatives
|
|
EP2647634A1
|
|
Indole-pyrimidine derivatives and their therapeutic uses
|
|
WO2012069428A1
|
|
Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
|
|
WO2011151359A1
|
|
Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
|
|
EP2527323A1
|
|
Urea carbonyl disulfide derivatives and their therapeutic uses
|
|
EP2527322A1
|
|
Carbamyl alkylphenyl disulfide derivatives and their therapeutic uses
|
|
EP2281824A1
|
|
Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
|
|
CN101952234A
|
|
Phenyl-prenyl derivatives, of marine and synthetic origin, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
|
|
EP2196466A1
|
|
Triple substituted phenanthroline derivatives for the treatment of neurodegenerative or heamatological diseases or conditions
|
|
MX2009001171A
|
|
N-phenyl-prenylamine derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders.
|
|
EP2002863A1
|
|
[1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
|
|
ZA200809951B
|
|
N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
|
